Olaplex ($OLPX) Investor Settlement
Olaplex has reached a settlement with $OLPX investors over claims that it failed to disclose risks tied to a now-banned ingredient in its top product.
Outline:
Olaplex marketed its products as part of a science-focused haircare brand. Investors later alleged the company failed to disclose risks related to an ingredient used in its top-selling product. In 2022, public attention to the ingredient and related concerns contributed to declining sales and a sharp stock drop. Investors filed suit and Olaplex later agreed to a settlement.
Timeline:
August 2020: The European Union announced that lilial would be banned in cosmetics beginning March 1, 2022.
June 2021: Olaplex reformulated its No. 3 Hair Perfector product to remove lilial.
September 29, 2021: Olaplex completed its IPO at $21 per share.
February 27, 2022: Social media posts raised concerns about lilial and the company’s products.
October 18, 2022: Olaplex reduced revenue guidance and $OLPX declined about 56.7%.
November 17, 2022: Investors filed a securities class action alleging omissions in IPO disclosures.
June 2025: Olaplex reached a settlement to resolve the claims.
Background:
Olaplex is a haircare company known for products marketed as science-based treatments designed to repair damaged hair. The company gained rapid popularity through online marketing and professional stylist endorsements.
Before its IPO in September 2021, Olaplex reformulated its No. 3 Hair Perfector product to remove lilial, a fragrance ingredient later banned in the European Union due to regulatory concerns. Investors later alleged the company did not disclose that earlier versions of the product contained the ingredient.
In early 2022, social media posts raised public attention to the ingredient issue. The resulting publicity led to reputational challenges and increased scrutiny of the company’s products and marketing claims.
Later in 2022, Olaplex reduced its revenue guidance, citing business challenges including reputational pressure and changes in consumer demand. Following these developments, investors filed a securities class action alleging that the company’s IPO disclosures omitted material information.
What Can Investors Expect Now?
Olaplex agreed to a settlement with $OLPX investors to resolve claims that it misled them about ingredient risks associated with its No. 3 Hair Perfector product.
If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section.